Leukemia, Radiation-Induced
"Leukemia, Radiation-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Leukemia produced by exposure to IONIZING RADIATION or NON-IONIZING RADIATION.
| Descriptor ID |
D007953
|
| MeSH Number(s) |
C04.557.337.650 C04.682.512 C26.733.345 G01.750.748.500.345
|
| Concept/Terms |
Leukemia, Radiation-Induced- Leukemia, Radiation-Induced
- Leukemia, Radiation Induced
- Radiation-Induced Leukemia
- Leukemias, Radiation-Induced
- Radiation Induced Leukemia
- Radiation-Induced Leukemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Radiation-Induced".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Radiation-Induced".
This graph shows the total number of publications written about "Leukemia, Radiation-Induced" by people in this website by year, and whether "Leukemia, Radiation-Induced" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Radiation-Induced" by people in Profiles.
-
Komaki R. My Path from Hiroshima to Houston. Pract Radiat Oncol. 2019 01; 9(1):1-2.
-
Quintás-Cardama A, Daver N, Kim H, Dinardo C, Jabbour E, Kadia T, Borthakur G, Pierce S, Shan J, Cardenas-Turanzas M, Cortes J, Ravandi F, Wierda W, Estrov Z, Faderl S, Wei Y, Kantarjian H, Garcia-Manero G. A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2014 Oct; 14(5):401-10.
-
Merchant S, Schlette E, Sanger W, Lai R, Medeiros LJ. Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. Arch Pathol Lab Med. 2003 Mar; 127(3):305-9.
-
Peterson LE, Cucinotta FA. Monte Carlo mixture model of lifetime cancer incidence risk from radiation exposure on shuttle and international space station. Mutat Res. 1999 Dec 06; 430(2):327-35.
-
Peterson LE, Dreyer ZE, Plon SE, Smith JL, Weinberg AD, McCarthy PL. Design and analysis of epidemiological studies of excess cancer among children exposed to Chernobyl radionuclides. Stem Cells. 1997; 15 Suppl 2:211-30.
-
Diamandidou E, Buzdar AU, Smith TL, Frye D, Witjaksono M, Hortobagyi GN. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol. 1996 Oct; 14(10):2722-30.
-
Waller LA, Turnbull BW, Gustafsson G, Hjalmars U, Andersson B. Detection and assessment of clusters of disease: an application to nuclear power plant facilities and childhood leukaemia in Sweden. Stat Med. 1995 Jan 15; 14(1):3-16.
-
Strom SS, Spitz MR, Cech IM, Annegers JF, Downs TD. Excess leukemia and multiple myeloma in a mining county in northeast Texas. Tex Med. 1994 Feb; 90(2):55-9.
-
Kantarjian HM, Estey EH, Keating MJ. Treatment of therapy-related leukemia and myelodysplastic syndrome. Hematol Oncol Clin North Am. 1993 Feb; 7(1):81-107.
-
Kantarjian H, Walters R. Implications of cytogenetic findings in secondary leukemia. Am J Clin Oncol. 1987 Oct; 10(5):453-6.